Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from West Virginia was posted on August 4, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Bph-Afa-8-4-25 Cdc041

Closed
GFO-0506-2600000000044-1State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541690
New
Federal
Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.
Solicitation # 7571PSQ00013
Solicitation 7571PSQ00013 is a competitive request for quote for an executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) for the NIH Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) and the HEAL Initiative. The selected contractor will act as a member of the External Oversight Committee (EOC), providing strategic guidance, programmatic reviews, and mentorship to advance the discovery and development of safe, non-addictive therapeutics for pain and nervous system conditions. The primary goal is to support the advancement of at least two novel therapeutics into clinical trials within five years. This is a small business set-aside under NAICS code 541690. The contract is structured as a fixed-price purchase order with a base period from November 5, 2026, to November 4, 2027, and two optional one-year extensions, for a total potential duration of three years. The government anticipates approximately 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Performance will primarily occur at the contractor's site, with occasional visits to Bethesda, Maryland. Award decisions will be based on best value, with technical qualifications—specifically professional expertise in pharmaceutical development and pain, educational credentials, and collaborative experience—weighted significantly more than price and past performance. Proposed key personnel must be employees of the quoter by the start of performance and are subject to a salary cap based on the Executive Schedule, Level II. All quotes must be submitted by November 3, 2026, and require active registration in the System for Award Management.
Omas Strategic Buying Center - Professional Services

POSTED

1 day ago

DEADLINE

in 6 days
NAICS: 541690
New
Federal
Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network
Solicitation # 7571PS27Q00015
The Department of Health and Human Services, through the National Institute of Neurological Disorders and Stroke (NINDS), is soliciting a Firm Fixed Price purchase order for an executive-level Senior Advisor Subject Matter Expert (SME) with specialized expertise in Patient Advocacy. The selected contractor will serve on the Ultra-rare Gene-based Therapy (URGenT) External Counselor Board (ECB) to provide strategic guidance and technical feedback on drug discovery and development projects, specifically focusing on accelerating therapeutics for ultra-rare neurological diseases. Key responsibilities include recommending solutions for programmatic challenges, evaluating project milestones, and providing guidance on biologic drug discovery and gene-based therapy trials. The acquisition is a total set-aside for small business concerns under NAICS code 541690. The anticipated period of performance consists of a base year from November 6, 2026, to November 5, 2027, with two subsequent one-year options, totaling a maximum duration of three years. The government estimates a base effort of 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Awards will be based on best value, with technical qualifications regarding pharmaceutical development and pain expertise weighted significantly more than price and past performance. All quotes must be submitted by 1:00 PM Eastern Time on November 2, 2026, to the designated Contracting Officer.
Omas Strategic Buying Center - Professional Services

POSTED

1 day ago

DEADLINE

in 5 days

General Info

Documents

2

BPH-AFA-8-4-25 CDC041: 2026 WVU Office of Health Services Research Support

DOCX, High priority: read this firstrfp
High

GFO 0506 260000000044 - BPH-AFA-8-4-25 CDC041

PDF, High priority: read this firstrfp
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyWest Virginia Division of Health
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS